By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medinox, Inc. 

11575 Sorrento Valley Road, Suite 201

San Diego  California  92121  U.S.A.
Phone: 858-793-4820 Fax: 858-793-4823




Fuso Pharmaceutical Ind., Ltd.  In April 2000, Medinox entered into a co-development deal with Fuso Pharmaceutical Industries, Ltd. of Osaka Japan. This agreement covers the development of the injectable nitric oxide blocker, NOX-100, for the Japan territory.

Company News
Medinox, Inc. and Orient Europharma Co., Ltd. Announce Collaboration on Developing NOX-100, a New Anti-Hypotensive Drug 4/12/2010 9:05:46 AM
Medinox, Inc. Announces Clinical Results of Naproxen Prodrug 5/27/2009 8:45:02 AM
Medinox, Inc. Appoints George Ko To Board Of Directors 10/19/2005 5:12:22 PM
Medinox, Inc. And PUMC Pharmaceutical Co., Ltd. Agree To Collaborate On Developing NOX-100 Septic Shock Drug In China And South Korea10/19/2005 5:11:09 PM
Medinox, Inc. Announces The Presentation Of NOX-100 Septic Shock Clinical Results At The Sixth World Congress On Trauma, Inflammation, Shock And Sepsis In Munich, Germany On March 3, 2004. 10/19/2005 5:10:21 PM
Medinox, Inc. Discloses A Potential New Drug For The Treatment Of Sickle Cell Disease In A Paper Published In The British Journal Of Haematology10/19/2005 5:10:06 PM